Albuterol Sulfate Inhalation Solution
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
165 recalls · Class III, newest first
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
Failed impurities/degradation specifications: Out of specification for a related compound C.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Crystallization with subpotent out of specification assay results for chlorhexidine.
Crystallization with subpotent out of specification assay results for chlorhexidine.
Crystallization with subpotent out of specification assay results for chlorhexidine.
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.
Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.